glp-1 receptor agonists dizziness side effect Ozempic and Drugs: Risk of Severe Effects Gastrointestinal (GI) Side Effects of

EMA (2024)

GLP-1/glucagon co-agonists The development of these unimolecular formulations targeting both GLP-1 and glucagon receptors enhances the anorectic effect of GLP-1, provides a lipolytic and lipogenesis-inhibiting effect (Table 2)particularly at the hepatic leveland promotes thermogenic activity, thereby facilitating weight reduction and the treatment of MASLD.1,5,35 Survodutide generates dose-dependent weight reduction of up to 14.9% in 46 weeks.49 It is shown to be effective in reducing liver fat and improving MASH in up to 62% of participants treated with weekly injection of 4.8 mg

& Prez-Fras, J

10.1088/1741-2552/ac9085 J

Suelen formularse junto a cido hialurnico y vitaminas hidrosolubles por sus propiedades antioxidantes y antiinflamatorias

Sublingual bypasses gut absorption and is effective at 5001,000 mcg/day